MacroGenics CEO Scott Koenig to step down; search committee formed

MACROGENICS INC

Scott Koenig to depart as President and CEO effective Feb 28, 2025; will resign from Board on same date.
Separation includes 24 months salary continuation, target bonus, COBRA, and accelerated vesting of 50% of unvested equity.
Continuing as advisor until Feb 28, 2030, with continued vesting of remaining unvested equity awards.
Board formed special committee and retained Heidrick & Struggles to identify new CEO.
Company highlights strong balance sheet and pipeline of antibody-based cancer therapeutics.

item 5.02 item 8.01 item 9.01

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Departed

Scott Koenig

President and Chief Executive Officer

MGNX · MACROGENICS INC

Effective: 2025-02-28
Filed: October 30, 2024, 7:59 PM ET

On October 25, 2024, Dr. Scott Koenig, the President and Chief Executive Officer of MacroGenics, Inc. (the “ Company ”) and the Company entered into a separation and consulting agreement, dated October 25, 2024 (the “ Separation Agreement ”), which provides for the terms of Dr. Koenig’s separation from employment, effective February 28, 2025

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Scott Koenig resigned as President and Chief Executive Officer at MACROGENICS INC.

Action: resigned
Role: President and Chief Executive Officer

Exact text from the filing

On October 25, 2024, Dr. Scott Koenig, the President and Chief Executive Officer of MacroGenics, Inc. (the “ Company ”) and the Company entered into a separation and consulting agreement, dated October 25, 2024 (the “ Separation Agreement ”), which provides for the terms of Dr. Koenig’s separation from employment, effective February 28, 2025

View on SEC.gov

MACROGENICS INC filing history →

Source: SEC EDGAR

accession 0001193125-24-247017

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.